Project Grant R13DK139769
Award Date
4/1/24
Completion Date
4/30/25
Dollars Obligated
$10K
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Linthicum Heights, MD 21090, USA
Similar Awards
This $1,124,825 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will support research at the University of Texas Health Science Center at San Antonio (UTHSCSA) to identify novel therapeutic targets for aggressive prostate cancer through induced pluripotent stem cell modeling of BRCA2 mutant prostate tissue. The award, which runs from August 1, 2024 to July 31, 2027, will enable UTHSCSA to conduct innovative scientific...
This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $1,444,922.00 to the University of Texas MD Anderson Cancer Center (MD Anderson) to conduct research on a novel epigenetic determinant in metastatic prostate cancer. The award period is from September 15, 2024 to September 14, 2027. MD Anderson, a comprehensive cancer research and treatment center, will utilize this funding to carry out basic,...
The National Institute on Aging (NIA) awarded a $489,509 Project Grant (CFDA 93.866 - Aging Research) to the Magee-Womens Research Institute And Foundation to conduct research on steroid hormone pathways regulating benign prostate hyperplasia (BPH) and lower urinary tract symptoms (LUTS) associated with aging. The 2-year project aims to: Identify proteins and pathways involved in promoting smooth muscle relaxation and bladder voiding that are dysregulated in aged mouse prostate models and...
This $103,000 Project Grant award from the National Cancer Institute under the Cancer Biology Research (CFDA 93.396) program supports the 2025 Gordon Research Conference and Gordon Research Seminar on Epithelial Differentiation and Keratinization. The conference and seminar will take place from May 31 to June 6, 2025 in Ventura Beach, California. This biennial conference is the leading international meeting in the field of epithelial biology, bringing together world-renowned experts to advance...
This Project Grant award of $1,412,000 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a biorepository and community development project to characterize aggressive urothelial cancer variants. The University of Washington, as the prime awardee, will conduct this research over a period of approximately 4 years, from September 2024 through August 2028. The project aims to expand understanding of aggressive forms of urothelial (bladder)...
The Department of the Army Medical Command awarded a $2.28 million Project Grant to the University of California, Los Angeles to support research titled "Identification of Spatial Regulatory Heterogeneity in Prostate Cancer Using Single-Nucleus Joint Profiling of Chromatin Architecture and DNA Methylation." The research will be conducted from June 2022 to June 2025 under the Military Medical Research and Development program (CFDA 12.420). This program supports basic, applied, and...
This Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) will support a study titled "BEST CARE FOR RECURRENT NMIBC: BLADDER-SPARING THERAPY AND CYSTECTOMY AS TREATMENTS". The $1,039,794 award, with a project period of Jul 1, 2024 to Jun 30, 2029, will be used by the University of Washington to: Compare long-term clinical and patient-reported outcomes between patients with recurrent non-muscle invasive...
This three-year Project Grant award of $739,289 from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) will fund research to revisit antiangiogenic therapy approaches to target prostate cancer metabolism. The University of Texas M.D. Anderson Cancer Center in Houston, Texas will lead the effort starting September 1, 2022. As part of the award, two co-investigators at Baylor College of Medicine will utilize mass spectrometry imaging to...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $260,250 to Health Research, Inc. (a not-for-profit research organization located in Buffalo, NY) to investigate "The Role of SLC45A3-ELK4 Chimera as a Molecular Determinant of Prostate Cancer Health Disparity." The research aims to advance the understanding of genetic mechanisms underlying prostate cancer progression and health...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,458,000.00 to The University of Texas MD Anderson Cancer Center to conduct research on "The Role of Androgens in Regulating Extracellular Vesicle Secretion and Molecular Cargo Loading by Prostate Cancer Cells." The 3-year project, beginning on March 1, 2024, aims to investigate how androgens, male sex hormones, influence the...